NEWS & EVENTS

Press releases

Inotrem announces FDA clearance of Investigational New Drug (IND) for the phase IIB ASTONISH trial in septic shock patients to demonstrate nangibotide efficacy

Paris (France). August 6. 2019. Inotrem S.A., a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, announced today the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application for the ASTONISH trial (Phase IIb) where the safety, tolerance and efficacy of nangibotide (LR12),

Read More »
Events

HealthTech Investor Days

June 24. & June 25. 2019 in Paris. Inotrem will attend this exclusive event organized by France Biotech which brings together French and European HealthTech leaders, large pharmaceutical companies and international investors in health innovation.

Read More »
Events

PharmaBoardRoom

May 5. 2019. Discover the interview of Jean-Jacques Garaud, CEO of Inotrem, laying out Inotrem’s recent milestones and internationalization strategy in PharmaBoardRoom.

Read More »
Events

France Biotech

February 19. 2019 in Paris. Martin Koch, COO of Inotrem, participates to “Market Access and Biotechnologies”, a panel discussion organized by France Biotech, France’s main non-profit organization which brings together the country’s leading innovative health companies and their expert partners. www.france-biotech.fr

Read More »
Events

Reanimation 2019

January 23.-26. 2019 in Paris. Reanimation 2019 is the Annual congress organized by the French Intensive Care Society (www.srlf.org). Dr. Bruno François, Coordinating Physician at the CHU of Limoges, will present the MOT-C-201 Clinical Trial Results regarding safety and tolerability of nangibotide (LR12) in patients with septic shock. www.reanimation-lecongres.com

Read More »
Events

International Sepsis Forum

October 1-3, 2018 in Bangkok, Thailand The International Sepsis Forum (ISF) is an international collaboration to reduce the global burden of sepsis guided by prominent academics from around the world. Sepsis 2018 will be held as a joint meeting with the Thai Society of Critical Sepsis 2018 Medicine. http://internationalsepsisforum.com/

Read More »

18th Annual Biotech in Europe Forum

October 3-4. 2018 in Basel, Switzerland The 18th Annual Biotech in Europe Forum is recognized as the leading international stage for those interested in investing and partnering in the biotech and life science industry. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading

Read More »

Bio-Europe

November 5-7. 2018 in Copenhagen, Denmark The 23rd annual international partnering conference BIO-Europe offers world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business. https://ebdgroup.knect365.com/bioeurope/

Read More »

Martin Koch joins Inotrem as Chief Operating Officer

Paris, January 18th . 2018. Inotrem S.A., a biotechnology company specialized in the control of acute inflammatory syndromes such as septic shock, has appointed Martin Koch as Chief Operating Officer (COO). Martin Koch comes to Inotrem with more than 25 years of experience in the healthcare industry. Prior to joining

Read More »

Inotrem and Roche Diagnostics sign a R&D collaboration agreement in the field of septic shock to develop a companion diagnostic test

Paris, November 10, 2017. Inotrem S.A., a biotechnology company specialized in the control of acute inflammatory syndromes, such as septic shock, today announced a R&D collaboration agreement with Roche Diagnostics to develop a companion diagnostic test using a soluble plasma circulating protein (sTREM-1) developed by Inotrem and the Roche proprietary

Read More »